Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New blood test could spot hidden tumors behind high blood pressure

NCT ID NCT01022515

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 28 times

Summary

This study looked at whether a new blood marker called EM66 can help doctors tell the difference between high blood pressure caused by rare adrenal tumors (pheochromocytoma or paraganglioma) and regular high blood pressure. Researchers measured EM66 levels in 60 adults with suspected tumors or known genetic risk. The goal is to improve diagnosis and avoid unnecessary treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CIC 9301

    Lille, 59000, France

  • CIC 9304

    Paris, 75012, France

  • Cardiology Department

    Paris, 75012, France

  • Cic-Crb 0204

    Rouen, 76000, France

  • Endocrinology Department

    Lille, 59000, France

  • Endocrinology Department

    Rouen, 76000, France

  • Endocrinology Department, Gustave-Roussy Institute

    Villejuif, 94000, France

  • Inserm U982/EA 4310; Rouen University (DC2N)

    Mont-Saint-Aignan, 76800, France

Conditions

Explore the condition pages connected to this study.